LISAvienna: e-Newsletter with news reviews and updates on funding opportunities published

What is currently going on in the Viennese biotechnology, pharmaceutical and medical device sector? Our newsletter provides you with selected news from companies and research institutions. This time, we focus e.g. on 40 years of TBE vaccine production in Austria, management news from AIT and Arsanis, the acquisition of MedEval by Diagnosia and an interesting publication by Vetmeduni Vienna.

Just in time for Easter, we summarize some of the last weeks’ highlights for you and remind you of important deadlines concerning funding opportunities and trade fairs. In addition, are you familiar with the advantages of the aws support scheme License.IP yet? Have you registered for the delegation trip to Taiwan and China, or taken advantage of a reduced fee for eHealth Summit Austria? Read through the March edition of our newsletter. This time, we have also included a link to the pdf file or our bi-annual printed “Highlights” publication.

Read the March edition 

Register for the e-Newsletter 

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)lisavienna.at.